Risk of Major Malformations in Infants Following First-Trimester Exposure to Quetiapine-Reference-Cited by-同舟云学术

Risk of Major Malformations in Infants Following First-Trimester Exposure to Quetiapine

Published:2018-12 Issue:12 Volume:175 Page:1225-1231
ISSN:0002-953X
Container-title:American Journal of Psychiatry
language:en
Short-container-title:AJP

Author:

Cohen Lee S.¹,Góez-Mogollón Lina¹,Sosinsky Alexandra Z.¹,Savella Gina M.¹,Viguera Adele C.¹,Chitayat David¹,Hernández-Díaz Sonia¹,Freeman Marlene P.¹

Affiliation:

1. From the Department of Psychiatry and the Ammon-Pinizzotto Center for Women’s Mental Health, Massachusetts General Hospital, Boston; Harvard Medical School, Boston; the Neurological Institute, Cleveland Clinic, Cleveland; the Prenatal Diagnosis and Medical Genetics Program, Mount Sinai Hospital, Toronto; and the Harvard T.H. Chan School of Public Health, Harvard University, Boston.

Publisher

American Psychiatric Association Publishing

Subject

Psychiatry and Mental health

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Antipsychotic Drug Use During Pregnancy Associated with Increased Malformation Rates and Worsening of Maternal and Infant Outcomes? A Systematic Review;Current Neuropharmacology;2024-12

2. Outcomes of long-acting injectable antipsychotics use in pregnancy: A literature review;World Journal of Psychiatry;2024-04-19

3. Psychopharmacology During Pregnancy and Lactation;The American Psychiatric Association Publishing Textbook of Psychopharmacology;2024-03-22

4. Quetiapine;The American Psychiatric Association Publishing Textbook of Psychopharmacology;2024-03-22

5. Effects of Prenatal Exposure to Second-Generation Antipsychotics on Development and Behavior Among Preschool-Aged Children;The Journal of Clinical Psychiatry;2024-03-13